PlainRecalls
FDA Drug Moderate Class II Terminated

Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.

Reported: January 28, 2015 Initiated: December 31, 2014 #D-0379-2015

Product Description

Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.

Reason for Recall

Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.

Details

Units Affected
2,428 vials
Distribution
Nationwide and Australia
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.. Recalled by Valeant Pharmaceuticals North America LLC. Units affected: 2,428 vials.
Why was this product recalled?
Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 28, 2015. Severity: Moderate. Recall number: D-0379-2015.